The report contains ten-year analysis with the following sections
contact us for pricing
Check out our sample pages |
Many companies now available
Search to find companies of interest
read summary of their published patent
the company report contains more information
u3 pharma | 201 |
amgen | 140 |
daiichi sankyo europe | 38 |
daiichi sankyo company ltd | 34 |
dalichi sankyo europe | 1 |
daiichi sankyo europe | 19 |
amgen | 17 |
u3 pharma | 2 |
dalichi sankyo europe | 1 |
daiichi sankyo company ltd | 1 |
Title of patent family (most common patent title) |
Family members |
Filing year |
---|---|---|
antibodies directed to her-3 and uses thereof | 55 | 2005 |
material and methods for treating or preventing her-3 associated diseases | 51 | 2009 |
heparin-binding epidermal growth factor-like growth factor antigen binding proteins | 39 | 2007 |
axl antibodies | 32 | 2007 |
humanized axl antibodies | 25 | 2009 |
anti-her3 antibody-drug conjugate | 18 | 2014 |
her3 inhibitor for modulating radiosensitivity | 14 | 2012 |
nucleic acid biomarker and use thereof | 11 | 2013 |
activated her3 as a marker for predicting therapeutic efficacy | 11 | 2006 |
protein biomarker and uses thereof | 8 | 2013 |